Stem cell advance offers prospect of cure for genetic liver diseases
By Sharon Kingman
Friday, December 6, 2013
LONDON – Physicians will soon attempt to treat patients with liver diseases caused by single-gene defects, by performing highly specific gene therapy on single liver stem cells, then growing up the genetically engineered cells and transplanting them back into the liver via an injection in the portal vein. The method could be applied to many different single-gene disorders, so long as a technique exists to grow the stem cells from the affected tissue that needs treating. Although the study that provides proof that the method works was carried out using stem cells from patients with cystic fibrosis, researchers are not currently planning clinical studies focusing on cystic fibrosis.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.